Influenza

>

Latest News

Respiratory virus vaccines on deck for 2024 /image credit vaccine vials: ©Mr.Ilkin/stock.adobe.com
Respiratory Virus Vaccines on Deck for 2024

March 22nd 2024

Respiratory vaccine R & D at Moderna, Merck, and Pfizer is focused on mRNA technology, added protection for vulnerable populations, and combination shots.

CDC: Persons with COVID-19, Flu, RSV, Other Respiratory Viruses No Longer Have to Isolate for 5 Days / Image credit: ©mdbildes/AdobeStock
CDC: Persons with COVID-19, Flu, RSV, Other Respiratory Viruses No Longer Have to Isolate for 5 Days

March 5th 2024

COVID-19 Hospitalization Raises Long-Term Mortality Risk Compared to Seasonal Flu: Daily Dose / image credit: ©New Africa/AdobeStock
COVID-19 Hospitalization Raises Long-Term Mortality Risk Compared to Seasonal Flu: Daily Dose

February 16th 2024

COVID-19 Hospitalization Linked to Higher Long-Term Mortality Risk Compared to Seasonal Influenza, Shows New Research / Image credit: ©Valerii/AdobeStock
COVID-19 Hospitalization Linked to Higher Long-Term Mortality Risk Compared to Seasonal Influenza, Shows New Research

February 9th 2024

Daily Dose: Hospitalization for COVID-19 vs for Flu Linked to More Long-Term Outcomes / image credit: ©New Africa/AdobeStock
Daily Dose: Hospitalization for COVID-19 vs for Flu Linked to More Long-Term Outcomes

January 17th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.